Company profile
ADAPTIN BIO, INC. CIK 1938571
Ticker
APTN (OTC)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Charlotte, NC 28277
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$5.17M
Total assets
$619.2K
Total liabilities
$2.11M
Stockholders' equity
-$1.49M
Cash & equivalents
$459.2K
Operating income
-$5.41M
Operating cash flow
-$4.78M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-04-01. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
340.6%
Equity / assets
-240.6%
CapEx / revenue
—
Operating cash flow / net income
0.92×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$5.17M
$619.2K
$2.11M
-$1.49M
2024
—
-$3.12M
$239.4K
$4.34M
-$4.10M
2023
—
-$85.6K
$380
$113.3K
-$977.6K
2022
—
—
$500
$27.8K
-$27.3K
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 424B3
2026-09-10
Financials filed via
Form 10-K
filed 2026-04-01
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Charlotte, NC 28277
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:49 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.